The US FDA has requested the manufacturers of rosiglitazone [Avandia] and pioglitazone [Actos] to add a boxed warning

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1157卷 / 1期

关键词：

Public Health; Heart Failure; Congestive Heart Failure; Rosiglitazone; Pioglitazone;

D O I：

10.2165/00128415-200711570-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 17 条

[1] Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure
Wooltorton, E
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (02) : 219 - 219
[2] The US FDA has added a new boxed warning to Plavix [clopidogrel].
Reactions Weekly, 2010, 1293 (1) : 2 - 2
[3] US FDA orders boxed warning for all glitazones
Reactions Weekly, 2007, 1165 (1) : 3 - 3
[4] US FDA requires boxed warning and REMS for metoclopramide
Reactions Weekly, 2009, 1242 (1) : 2 - 2
[5] US FDA removes boxed warning from canagliflozin products
Reactions Weekly, 2020, 1820 (1) : 5 - 5
[6] US FDA votes for ban or boxed warning on paracetamol combination products
Reactions Weekly, 2009, 1260 (1) : 2 - 2
[7] Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning
Bratsman, Andrew
Mathias, Kristen
Laubscher, Rory
Grigoryan, Larissa
Rose, Stacey
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (06) : 701 - 707
[8] Pressure on US FDA to add black box warning to fluoroquinolones
Reactions Weekly, 2006, 1118 (1) : 2 - 2
[9] FDA directs antidepressant manufacturers to add pediatric suicidality 'black box' warning to labelling
不详
FORMULARY, 2004, 39 (11) : 523 - 523
[10] The US FDA has sent warning letters to eight manufacturers and 12 distributors to stop manufacturing and distributing unapproved ergotamine
Reactions Weekly, 2007, 1142 (1) : 2 - 2